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Introduction: Dental pulp stem cells (DPSCs) are mesenchymal stem cells located in dental pulp and are thought
to be a potential source for cell therapy since DPSCs can be easily obtained from teeth extracted for orthodontic
reasons. Obtained DPSCs can be cryopreserved until necessary and thawed and expanded when needed. The aim
of this study is to evaluate the therapeutic potential of DPSC transplantation for diabetic polyneuropathy.
Methods: DPSCs isolated from the dental pulp of extracted incisors of Sprague–Dawley rats were partly frozen in a
−80 °C freezer for 6 months. Cultured DPSCs were transplanted into the unilateral hindlimb skeletal muscles 8 weeks
after streptozotocine injection and the effects of DPSC transplantation were evaluated 4 weeks after the transplantation.
Results: Transplantation of DPSCs significantly improved the impaired sciatic nerve blood flow, sciatic motor/sensory nerve
conduction velocity, capillary number to muscle fiber ratio and intra-epidermal nerve fiber density in the transplanted side of
diabetic rats. Cryopreservation of DPSCs did not impair their proliferative or differential ability. The transplantation of
cryopreserved DPSCs ameliorated sciatic nerve blood flow and sciatic nerve conduction velocity as well as freshly isolated DPSCs.
Conclusions:We demonstrated the effectiveness of DPSC transplantation for diabetic polyneuropathy even when using
cryopreserved DPSCs, suggesting that the transplantation of DPSCs could be a promising tool for the treatment of diabetic
neuropathy.Introduction
Dental pulp stem cells (DPSCs), which are mesenchymal
stem cells located in the dental pulp cavity [1, 2], are con-
sidered a possible cell source for regenerative medicine
since DPSCs can be obtained from extracted teeth without
an additional invasion, such as from wisdom teeth or pre-
molars extracted for orthodontic reasons. DPSCs are
highly proliferative and can differentiate into osteoblasts,
odontoblasts, adipocytes, and neuronal cells [3, 4]. The* Correspondence: narusek@dpc.agu.ac.jp
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regeneration [5–7] and spinal cord injury [8].
Diabetic polyneuropathy (DPN) is the most common
and early developing complication in both type 1 and
type 2 diabetes [9]. Its various symptoms not only re-
duce the quality of life, but the existence of DPN affects
mortality [10]. Although recent anti-symptomatic drugs
are effective for diabetic nerve pain [11], a more effective
treatment is needed to cure DPN.
We suggest that progenitor/stem cell transplantation
is a potentially useful therapy for the treatment of DPN
since it improves the nerve blood flow and nerve con-
duction velocity as well as the sensory disorder indistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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determined that the impairment of cell function by dia-
betes occurs in progenitor/stem cells [15–17]. Aging also
impairs progenitor/stem cells [18, 19]. Recently, we dem-
onstrated that the therapeutic efficacy of bone marrow-
derived mononuclear cells (MNCs) for DPN was impaired
in MNCs from aged rats compared with those from young
rats [20].
DPSCs could be isolated from the teeth extracted by
for orthodontic reasons in people by their 20s. If DPSCs
isolated from young teeth can be cryopreserved for fu-
ture use, some of the problems of diabetes and aging
may be treated. In this paper, we investigated whether
transplantation of DPSCs can improve DPN. Further-
more, to investigate the viability of cryopreserved DPSCs
(cryo-DPSCs), we compared the proliferative and differ-
ential ability of freshly isolated DPSCs (fresh-DPSCs)
and cryo-DPSCs and examined their therapeutic poten-
tial in DPN. We demonstrated that the transplantation
of fresh-DPSCs into hindlimb skeletal muscles amelio-
rated the sciatic nerve blood flow and sciatic nerve con-
duction velocity in association with the increased capillary
to muscle ratio and intra-epidermal nerve fiber density in
diabetic rats. The cryo-DPSCs showed equivalent ability
for proliferation and differentiation compared with the
fresh-DPSCs. Cryo-DPSC transplantation showed equiva-
lent efficacy for improving the nerve conduction velocity
and nerve blood flow in diabetic rats.
Methods
Isolation of rat DPSCs
Dental pulp was harvested from the extracted incisors of
6-week-old male Sprague–Dawley rats (Chubu Kagakushizai,
Nagoya, Japan) or green fluorescent protein (GFP)-transgenic
SD rats (SD-Tg(CAG-EGFP)Cz-0040sb; Japan SLC, Inc.,
Hamamatsu, Japan). DPSCs were isolated from the dental
pulp by digestion with phosphate-buffered saline contain-
ing 0.1 % collagenase and 0.25 % trypsin. DPSCs were
cultured with alpha modification of the Eagle’s medium
(α-MEM; GIBCO, Billings, MT, USA) supplemented
with 20 % fetal bovine serum embryonic stem cell-
qualified (GIBCO) [21]. DPSCs from passage 3 to 6 were
used for all experiments. All experimental protocols
were conducted according to the Regulations for Animal
Experiments in Aichi Gakuin University, and were
approved by the Institutional Animal Care and Use
Committees of Aichi Gakuin University.
Detection of cell surface markers
DPSCs at passage 3 were subjected to flow cytometric
analysis (FACS Calibur; Becton Dickinson, Franklin Lakes,
NJ, USA). Cells were stained with the FITC-conjugated
mouse monoclonal antibody against rat CD90, the FITC-
conjugated hamster antibody against rat CD29, andPE-conjugated mouse monoclonal antibodies against
rat CD34, CD49d, and CD45 (Becton Dickinson).
Isotype-identical antibodies served as controls. Data
were analyzed with CELLQUEST software (Becton
Dickinson) [22].
Animals and induction of diabetes
Six-week-old male Sprague–Dawley rats were provided
by Chubu Kagakushizai. Diabetes was induced by the in-
traperitoneal injection of streptozotocine (STZ; 60 mg/kg;
Sigma Chemical, St. Louis, MO, USA). Control rats re-
ceived an equal volume of citric acid buffer.
Transplantation of DPSCs
Eight weeks after the induction of diabetes, 1 × 106
cells/limb of DPSCs in 1.0 ml saline were injected into
10 points in the unilateral hindlimb skeletal muscles of
the normal and diabetic rats. Vehicle (saline) was injected
into the hindlimb muscles of the other side as the control.
Four weeks after the transplantation, the following mea-
surements were performed.
Sciatic nerve conduction velocities
Rats were anesthetized with isopentane and placed on a
heated pad in a room maintained at 25 °C to ensure a
constant rectal temperature of 37 °C. Motor nerve con-
duction velocity (MNCV) between the ankle and sciatic
notch, and sensory nerve conduction velocity (SNCV)
in the sciatic nerve between the ankle and knee were
measured using a Neuropak NEM-9400 instrument
(Nihon-Koden, Osaka, Japan).
Sciatic nerve blood flow
Sciatic nerve blood flow (SNBF) was measured by
laser-Doppler flowmeter (FLO-N1, Omegawave, Tokyo,
Japan). The skin of an anesthetized rat was cut along the
femur and then an incision through the fascia was care-
fully made to expose the sciatic nerve. The blood flow
was measured by a laser-Doppler probe placed 1 mm
above the nerve.
Tissue collection
Rats were killed by an overdose of pentobarbital. The so-
leus muscles and footpads from both sides were ob-
tained from the normal and the diabetic rats. Extracted
tissues were fixed by 4 % paraformaldehyde overnight,
and then embedded in paraffin.
Capillary number to muscle fiber ratio
The soleus muscles in paraffin were cut into 5-μm sec-
tions for immunohistochemical staining. The sections
were incubated overnight at 4 °C with the primary anti-
body (anti-vWF polyclonal antibody; DAKO Japan,
Tokyo, Japan) diluted 1:600 and subsequently stained
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according to the manufacturer’s instructions. The nega-
tive control was performed by omitting the anti-vWF
antibody.
The sections were also stained with the primary anti-
body (anti-PECAM-1 polyclonal antibody; Santa Cruz
Biotechnology Inc., Dallas, TX, USA) diluted 1:200 and
visualized using Alexa fluor 594 anti-rabbit secondary
antibody (Invitrogen, Carlsbad, CA, USA). Nuclei were
stained with 4’-6-diamidino-2-phenylindole (DAPI). The
capillary to muscle ratio was counted under a fluores-
cence microscope (×200).
Location and differentiation of transplanted DPSCs in
skeletal muscles
To investigate the survival and the differentiation of
transplanted DPSCs, DPSCs isolated from GFP rats
were transplanted into the hindlimb skeletal muscles
of diabetic rats. Four weeks after the transplantation,
the DPSC-transplanted skeletal muscles were excised
and fixed in 4 % paraformaldehyde. The specimens
were embedded within an OCT compound (Sakura
Finetechnical, Tokyo, Japan) and cut into 5-μm sections.
The sections were stained with the primary antibody
against PECAM-1 (1:400), FABP (1:100), osteocalcin
(1:100) (R&D Systems, Minneapolis, MN, USA), neuronal
nuclei (NeuN) (1:400; Millipore, Billerica, MA, USA), and
glial fibrillary acidic protein (1:400; Santa Cruz). After
washing, the sections were incubated with the Alexa fluor
594-conjugated secondary antibodies. DAPI was detected
as cell nuclei. Sections were observed under a fluorescence
microscope FV10i confocal system (Olympus, Tokyo,
Japan).
Intra-epidermal nerve fiber density
The paraffin-embedded footpads were cut into 8-μm
sections. The sections were incubated overnight at 4 °C
with the primary antibody (anti-PGP9.5 antibody; Abnova,
Taipei City, Taiwan) diluted 1:400 and subsequently
stained using the Simplestain rat system (Nichirei) accord-
ing to the manufacturer’s instructions. The negative con-
trol was performed by omitting the anti-PGP9.5 antibody.
Each individual nerve fiber with branching in the epider-
mis from the dermis was counted. Intra-epidermal nerve
fiber density (IENFD) was measured blindly in 10 fields
from each section by three independent investigators
under light microscopy (×200) and was expressed as epi-
dermal nerve fiber number per length of epidermal base-
ment membrane [23, 24].
mRNA expression of cultured DPSCs and hindlimb
skeletal muscles
RNA was extracted from cultured DPSCs and the frozen
samples of hindlimb skeletal muscles using TRIzol Reagent(Invitrogen) according to the manufacturer’s instructions.
Starting from 1 μg RNA, cDNA was synthesized using
ReverTra Ace (Toyobo, Osaka, Japan) according to the
manufacturer’s descriptions. Primers and probes for basic
fibroblast growth factor (bFGF), vascular endothelial
growth factor (VEGF), nerve growth factor (NGF),
neurotrophin-3 (NT-3) and 18S rRNA and β2 microglob-
ulin for the endogenous control were purchased from
Taqman Gene Expression Assays (Applied Biosystems,
Foster City, CA, USA). Polymerase chain reaction (PCR)
products were visualized by agarose gel (Wako, Osaka,
Japan)/ethidium bromide (Sigma). Real-time quantitative
PCR (qRT-PCR) was performed and monitored by the
ABI PRISM 7000 Sequence Detction System (Applied
Biosystems). The relative quantity was calculated by the
by the ΔΔCt method.
Cryopreservation and thawing of DPSCs
After DPSCs were cultured at passage 3, the cells were
harvested with trypsin-EDTA, resuspended with CELL-
BANKER (Amsbio, Cambridge, MA, USA) and frozen in
a cryotube in a −80 °C freezer for 6 months.
When thawing, cells were immediately thawed in a 37 °
C water bath and then added to 10 ml of the cultured
medium containing fetal bovine serum. After the cells
were washed three times with phosphate-buffered saline,
thawed DPSCs were cultured in a plastic dish with α-MEM
supplemented with 20 % fetal bovine serum and used as
cryo-DPSCs.
Adipogenic or osteogenic differentiation assay
For the differentiation assay, fresh-DPSCs and cryo-
DPSCs at passage 3 to 4 were cultured for 2–3 weeks in
the induction medium according to the manufacturer’s
instructions (R&D Systems). Adipogenic differentiation
medium contained 1 % h-insulin, 2 % L-glutamine, 10 %
mesenchymal cell growth supplement, 0.5 % dexametha-
sone, 0.2 % indomethacin, and 0.1 % 3-isobutyl-methyl-
xanthine. Adipogenic maintenance medium contained 1
% h-insulin, 2 % L-glutamine, and 10 % mesenchymal
cell growth supplement. For the detection of adipogenic
differentiation, we stained the lipid accumulation with
oil red O (Polyscience, Warrington, PA, USA).
Osteogenic induction medium contained 0.5 % dexa-
methasone, 2 % L-glutamine, 0.5 % ascorbate, 1 % β-
glycerophosphate and 10 % mesenchymal cell growth
supplement. We detected osteogenic differentiation
with alkaline phosphatase (ALP) activity using an ALP
detection kit (Millipore).
Proliferation assay
Fresh-DPSCs and cryo-DPSCs were seeded onto six-well
plates at 1 × 104 cells/well. The growth of DPSCs was
determined by cell counts at days 3 and 5 after seeding.
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trypsin and were centrifuged at 1200 rpm for 5 min. The
cell number was counted with a hemocytometer.
The proliferative potential of DPSCs was assessed by
the MTT assay according to the manufacturer’s proced-
ure (Cayman Chemical Company, Ann Arbor, MI, USA).
After 3 and 5 days of culture, cells were seeded in 96-
well culture plates (1 × 103 cells/well) and incubated for
another 6 h. Then MTT Reagent was added and the
cells were incubated for 3 h to reveal the formazan dark
crystals. Crystal-dissolving solution was added to each
well and the absorbance was determined at 570 nm with
a microplate reader.Statistical analysis
All results are expressed as mean ± SEM. Statistical ana-
lysis was performed by Student's t-test for comparisons
between two groups and one-way analysis of variance
followed by Bonferroni correction for multiple com-
parisons. The significant difference was indicated at the
P < 0.05 level.Results
Body weights and blood glucose concentrations of rats
At 12 weeks after STZ injection, diabetic rats showed se-
vere hyperglycemia (normal rats: 95.5 ± 6.4 mg/dl; dia-
betic rats: 401.3 ± 43.7 mg/dl; P < 0.01) and significantFig. 1 Morphology and characterization of fresh-DPSCs. a Cultured DPSCs
cytometric analysis of fresh-DPSCs. The expression of the surface markers w
histograms, isotype controls; filled histograms, stained with the specific surreductions in body weight (normal rats: 510.5 ± 19.0 g;
diabetic rats: 313.0 ± 23.9 g; P < 0.01).Characteristics of DPSCs
Phase-contrast microscopic images of cultured DPSCs
are shown in Fig. 1a. DPSCs were identified by their typ-
ical spindle-shape morphology. The surface markers of
DPSCs showed high expression of CD29 and CD90,
which are common stem cell markers in mesenchymal
stem cells and DPSCs (Fig. 1b). DPSCs also showed rela-
tively high expressions of CD49d, but lacked the expres-
sion of CD34 and CD45 [22]. The purity of DPSCs was
achieved by passages and we found approximately 90 %
purity after 3 passages. The differentiation ability of cul-
tured DPSCs has already been confirmed in our previous
paper [21].Fresh-DPSC transplantation ameliorates impaired MNCV,
SNCV and SNBF in the diabetic rats
Eight-weeks after the STZ injection, we transplanted
fresh-DPSCs into the unilateral hindlimb skeletal mus-
cles. Neurophysiological measurements were performed
at 4 weeks after DPSC transplantation. MNCV and
SNCV in the vehicle-injected side of the diabetic rats
were significantly reduced compared with those of the
normal rats (Fig. 2a, b). DPSC transplantation signifi-
cantly ameliorated both MNCV and SNCV in theobserved with a phase contrast microscope. Bar = 100 μm. b Flow
as investigated with CD29, CD34, CD49d, CD45 and CD90. Open
face marker antibodies
A B C
Fig. 2 Effects of dental pulp stem cell (DPSC) transplantation on sciatic motor nerve conduction velocity (MNCV), sciatic sensory nerve
conduction velocity (SNCV) and sciatic nerve blood flow (SNBF). DPSCs were transplanted into the unilateral hindlimb skeletal muscles 8 weeks
after STZ injection. a MNCV. b SNCV. c SNBF. Diabetic rats showed significant reductions in MNCV, SNCV and SNBF. DPSC transplantation
improved them to almost the same level as those of the normal rats. Results are expressed as means ±SEM (n = 4) . *P < 0.05, **P < 0.01
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injected side of the diabetic rats (P < 0.01).
SNBF was also significantly decreased in the vehicle-
injected side (P < 0.05), which was significantly aug-
mented by the DPSC transplantation in the diabetic rats
(P < 0.05) (Fig. 2c). Transplantation of DPSCs in the
normal rats did not affect MNCV, SNCV, or SNBF.
Fresh-DPSC transplantation increases capillary density of
skeletal muscles in the diabetic rats
The vasculatures in the soleus muscles were visualized
by vWF immunostaining (Fig. 3a) and PECAM-1 immuno-
fluorescence staining (Fig. 3b). Quantitative analyses
revealed that the PECAM-1 positive endothelial cell to
muscle fiber ratio was significantly reduced in the
vehicle-injected side of diabetic rats compared with the
normal rats (P < 0.01) (Fig. 3c). Transplantation of DPSCs
significantly increased the PECAM-1 positive cell to
muscle ratio in diabetic rats.
To confirm whether the increased capillaries are of host
cell origin or from the differentiation into vascular endo-
thelial cells from transplanted DPSCs, we transplanted
GFP-DPSCs into diabetic rats. As shown in Fig. 3d, some
of the PECAM-positive vascular endothelial cells are ex-
pressing GFP, indicating that transplanted DPSCs differen-
tiated into vascular endothelial cells. Other PECAM-
positive endothelial cells were of host origin.
Transplanted DPSCs derived from GFP rats existed in the
skeletal muscles without differentiation into adipocytes,
osteoblasts, neuronal cells, or Schwann cells
Transplanted GFP-DPSCs existed around the muscle
bundles in the skeletal muscles. Immunohistological
staining revealed that transplanted GFP-DPSCs havenot differentiated into adipocytes, osteoblasts, neurons
or Schwann cells (Figure S1 in Additional file 1).
Transplantation of fresh-DPSCs increases IENFD in the
diabetic rats
To detect the sensory small nerve fiber damage in DPN,
we analyzed IENFD at the footpad, which is established
as a research tool for unmyelinated C and thinly myelin-
ated A delta fibers and considered as a surrogate marker
for small fiber neuropathy [23]. Intra-epidermal nerve fi-
bers were visualized by PGP9.5 immunostaining (Fig. 4a).
Quantitative analyses revealed that IENFD was signifi-
cantly reduced by 50 % in the vehicle-injected side of
diabetic rats compared with the normal rats (P < 0.01)
(Fig. 4b), which was ameliorated by the transplantation
of fresh-DPSCs (P < 0.05).
Cultured DPSCs express mRNA expression of angiogenic
and neurotrophic factors
To confirm whether cultured DPSCs express angiogenic
and neurotrophic factors, we evaluated mRNA expres-
sion of VEGF, bFGF, NGF and NT-3 by RT-PCR. The
products were visualized by agarose gel electrophoresis.
As shown in Fig. 5a, DPSCs expressed all of these angio-
genic and neurotrophic factors.
Transplantation of fresh-DPSCs into skeletal muscles
tends to affect mRNA expression of neurotrophic and
angiogenic factors
To investigate whether DPSC transplantation affects
mRNA expression in the transplanted skeletal muscles,
we measured angiogenic and neurotrophic gene expres-
sions in the skeletal muscles on the transplanted side
and the vehicle-injected side. As shown in Fig. 5b, the
Fig. 3 Capillaries in the soleus muscles. a, b Representative photomicrographs of the histological sections in the skeletal muscles of normal and
diabetic rats. Capillaries were visualized by von Willebrand factor (vWF) (a) and PECAM-1 (b). Arrows indicate vascular endothelial cells stained by
vWF. Bar = 50μm. c Quantitative analysis for capillary to muscle fiber ratio of the skeletal muscles of normal and diabetic rats. Results are
expressed as means ± SEM (n = 4). **P < 0.01. d Differentiation of transplanted green fluorescent protein (GFP)-expressing dental pulp stem cells
(DPSCs) into vascular endothelial cells in the skeletal muscles 4 weeks after the transplantation. DPSCs from GFP-expressing rats were transplanted
into hindlimb skeletal muscles in the diabetic rats. Vascular endothelial cells were visualized by PECAM-1. Bar = 50 μm
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Fig. 4 Intra-epidermal nerve fiber density (IENFD). a Representative photomicrographs of the histological sections of the footpads of normal and
diabetic rats. Intra-epidermal nerve fibers (arrows) were detected by immunohistological staining for PGP9.5. Bar = 10μm. b Quantitative analysis
for IENFD of the footpads of normal and diabetic rats. Results are expressed as means ± SEM (n = 4). *P < 0.05, **P < 0.01. DPSC dental pulp
stem cell
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tors, especially bFGF and NGF, in the skeletal muscles
tended to be increased on the transplanted side com-
pared with those on the vehicle-injected side in both
normal and diabetic rats, although they were not
significant.
Characteristics of cryo-DPSCs are similar to those of
fresh-DPSCs
Cryo-DPSCs were thawed at 37 °C, re-cultured and ex-
panded. The cryo-DPSCs showed the typical spindle-
shaped morphology, which was the same as that of the
fresh-DPSCs (Fig. 6a). The surface marker analysis re-
vealed that cryo-DPSCs were positive for CD29, CD90
and CD49d and negative for CD34, CD45, which was
the same pattern shown by the fresh-DPSCs (Fig. 6b).
Differential and proliferative capability are preserved in
cryo-DPSCs
We assessed the capacity of fresh-DPSCs and cryo-
DPSCs to differentiate into adipocytes and osteoblasts.
After adipogenic induction for 3 weeks, the cells werestained with oil red O for the detection of adipogenesis.
Lipid cluster-positive cells were equally detected in both
fresh-DPSCs and cryo-DPSCs (Fig. 7a). For the osteo-
genic induction, cells were cultured in the osteogenic in-
duction medium for 2 weeks. ALP was identified at
similar levels in fresh-DPSCs and cryo-DPSCs (Fig. 7a).
We examined the proliferative potential of fresh-
DPSCs and cryo-DPSCs by cell count and MTT assay.
The growth rate was not different between fresh-DPSCs
and cryo-DPSCs by cell count (Fig. 7b). MTT assay
showed that there was no significant difference in the
proliferative potential between fresh-DPSCs and cryo-
DPSCs on day 3 and day 5 (Fig. 7c).
Impaired nerve function in the diabetic rats is
ameliorated by the transplantation of cryo-DPSCs
We evaluated the effects of fresh-DPSC transplantation
and cryo-DPSC transplantation on the nerve functions
in the diabetic rats. Eight weeks after STZ injection,
fresh-DPSCs or cryo-DPSCs were transplanted into the
unilateral hindlimb skeletal muscles in the diabetic rats
and neurophysiological measurements were performed 4
Fig. 5 mRNA expressions of basic fibroblast growth factor (bFGF) vascular endothelial growth factor (VEGF), nerve growth factor (NGF) and neurotrophin-3
(NT-3) in cultured dental pulp stem cells (DPSCs) and hindlimb skeletal muscles. amRNA levels of these factors in cultured DPSCs were evaluated by RT-PCR.
The products were visualized by agarose gel/ethidium bromide. b mRNA expressions of these factors in the hindlimb skeletal muscles were measured
by RT-PCR. The relative quantity was calculated by the by the ΔΔCt method. Results are expressed as means ± SEM (n = 5)
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layed MNCV and SNCV in the vehicle-injected side of
the diabetic rats were significantly augmented by cryo-
DPSC transplantation as well as fresh-DPSC transplant-
ation (P < 0.05 and P < 0.01, respectively). The trans-
plantation of fresh-DPSCs and cryo-DPSCs significantly
increased SNBF compared with that in the vehicle injec-
tion side in diabetic rats (P < 0.05). The level of MNCV,SNCV, and SNBF on the transplanted side did not sig-
nificantly differ between transplantations of fresh-DPSCs
and cryo-DPSCs.
Discussion
In this study, we revealed that the transplantation of cul-
tured DPSCs into the hindlimb skeletal muscles amelio-
rated DPN in rats. We compared the fresh-DPSCs with
A B
Fig. 6 Morphology and identification of cryo-DPSCs. a DPSCs, which were thawed after cryopreservation, were cultured and expanded. Cryo-DPSCs
were of similar shape as the fresh-DPSCs observed with the phase contrast microscope. Bar = 100 μm. b Flow cytometric analysis of cryo-DPSCs. The
expression of surface markers was analyzed with CD29, CD34, CD49d, CD45 and CD90. Open histograms, isotype controls; filled histograms, stained
with the specific surface marker antibodies
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not inferior in proliferative and differential ability com-
pared with the fresh-DPSCs, and maintained their thera-
peutic potential for DPN.
DPN, an early onset and most frequent complication
in diabetic patients, results from the impairment of
nerve blood flow and from metabolic disorders [24]. Al-
though recent anti-symptomatic drugs improve the
symptoms of DPN, the establishment of more essential
and effective treatments is needed. In this manuscript,
we revealed that the transplantation of DPSCs into hind-
limb skeletal muscles ameliorated the impaired MNCV,
SNCV and SNBF in diabetic rats. The capillary to
muscle fiber ratio of the diabetic rats was significantly
reduced compared with that of normal rats, but was
ameliorated by the transplantation of DPSCs. The dia-
betic rats also showed decreased IENFD on the footpad,
and the transplantation of DPSCs increased IENFD on
the footpad of the transplanted side. These results sug-
gest that the transplantation of DPSCs, as well as the
other types of mesenchymal stem cells, could have
therapeutic potential for DPN with the improvement of
both large and small size nerve fibers and nerve blood
flow [14, 25].
Previous experimental and clinical studies indicated
that vasodilator therapy has some promising effects onDPN [26, 27]. Here, we showed that DPSCs expressed
angiogenic genes, such as bFGF and VEGF, and the
DPSC transplantation into the hindlimb skeletal muscles
increased microvasculatures in the skeletal muscles, ac-
companied with an increase in the sciatic nerve blood
flow at the transplanted side. We used GFP-expressing
DPSCs and confirmed that a small number of the trans-
planted DPSCs differentiated into vascular endothelial
cells and directly participated in vasculogenesis, while
other microvasculatures were of host origin. Although
DPSCs can differentiate into many type of cells, most of
which are mesodermal in origin such as osteoblast, adi-
pocytes, and neurons [1, 21, 28, 29], we have not found
any differentiation into osteoblast, adipocytes, neuronal
cells, or Schwann cells. These results are consistent with
the previous results of the therapeutic transplantation of
other progenitor or stem cells [12, 14].
An important issue to be solved for autologous cell
transplantation in diabetic patients is the functional dis-
order of progenitor and mesenchymal stem cells. Like
other mature cells, the functions of progenitor and mes-
enchymal stem cells were impaired by hyperglycemia
and aging [16–19]. The efficacy of progenitor and stem
cell transplantation was affected by the activity of donor
cells [18, 20, 30]. DPSCs are isolated from dental pulp
and easily expanded in a culture condition. Dental pulp
Fig. 7 Differential potential and proliferative capacity of freshly
isolated dental pulp stem cells (fresh-DPSCs) and cryopreserved
dental pulp stem cells (cryo-DPSCs). a Adipogenic differentiation was
observed by oil red O staining. Osteogenic differentiation was
observed by alkaline phosphatase (ALP) activity. Bar = 250 μm. b
The growth of fresh-DPSCs and cryo-DPSCs was measured as the cell
number counted with a hemocytometer on day 3 and day 5 after
seeding. c The proliferative activity of fresh-DPSCs and cryo-DPSCs
was determined by the MTT assay on day 3 and day 5. Results are
expressed as means ± SEM (n = 9)
Fig. 8 Comparison of the transplantation effects of freshly isolated
dental pulp stem cells (fresh-DPSC) and cryopreserved dental pulp
stem cells (cryo-DPSCs) on neurophysiological disorder. Transplantation
of cryo-DPSCs significantly ameliorated the impaired motor nerve
conduction velocity (MNCV) (a) and sensory nerve conduction
velocity (SNCV) (b). These results were equal to those of fresh-DPSCs.
Transplantation of cryo-DPSCs and fresh-DPSCs significantly increased
the decreased sciatic nerve blood flow (SNBF) (c). Results are expressed
as means ± SEM (n = 4). *P < 0.05, **P < 0.01
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orthodontic reasons. Previous investigations demonstrated
that DPSCs isolated even 5 days after tooth extraction
have high proliferative activity [31, 32]. Importantly,
DPSCs were reported to maintain their proliferative and
differential ability and keep their immunosuppressive ac-
tivity even after cryopreservation [33, 34].
Our therapeutic strategy for DPSC transplantation
to treat DPN is as follows: DPSCs are isolated from
extracted teeth in young adults for orthodontic rea-
sons. Obtained DPSCs are cryopreserved before use.
Cryo-DPSCs are thawed and expanded in a culture
condition as needed. Re-cultured DPSCs are trans-
planted for the treatment of DPN. To ensure the pos-
sibility of this strategy, we have investigated whether
the transplantation of cryo-DPSCs ameliorated DPN
in STZ-induced diabetic rats. We determined that the
cryo-DPSC transplantation improved nerve conduc-
tion velocity and nerve blood flow as well as fresh-
DPSC transplantation. We also confirmed that cryo-
DPSCs expressed the same surface antigen pattern as
the fresh-DPSCs, and kept their potential to differen-
tiate into osteoblasts and adipocytes, which is consist-
ent with the results of a previous investigation [35].
The proliferative activity measured by cell count and
MTT assay was the same level in fresh-DPSCs and
cryo-DPSCs. These results indicate that DPSCs main-
tain their function and therapeutic efficacy for the
treatment of DPN after cryopreservation.
We have not evaluated for how long a single trans-
plantation of DPSCs keeps the amelioration of DPN.
We evaluated the effects of DPSC transplantation 4
weeks after transplantation in this study. The studies
on the transplantation of other types of cells, such as
mesenchymal stem cells and endothelial progenitor
cells, demonstrated that the stem/progenitor cell
transplantation ameliorated DPN 3 days to 12 weeks
after transplantation, suggesting that the effects main-
tain for at least 12 weeks [13, 14, 36]. Further study is
required on this issue.
Conclusion
We demonstrated for the first time that the transplant-
ation of fresh-DPSCs ameliorated nerve conduction
velocity and nerve blood flow with an increase in
IENFD in diabetic rats. Cultured DPSCs expressed an-
giogenic and neurotrophic factor genes, suggesting
their multi-function. Cryo-DPSCs maintained the pro-
liferative and differentiative potential at the same level
as fresh-DPSCs and the effects of cryo-DPSC trans-
plantation were not inferior to fresh-DPSC transplant-
ation. Since DPSCs can be isolated from teeth extracted
from young adults, the obtained DPSCs, which can be
cryopreserved until needed, are not only youthful but alsomay be stem cells before the onset of diabetes. These find-
ings suggest that DPSCs may be a promising cell source
for the treatment of DPN.
Additional file
Additional file 1: Figure S1. Transplanted GFP-expressing DPSCs
were located in the skeletal muscles without differentiation into
adipocytes, osteoblasts, neuronal cells, or Schwann cells. DPSCs from
GFP-expressing rats were transplanted into hindlimb skeletal muscles
in the diabetic rats. To analyze the differentiation of transplanted
DPSCs, The skeletal muscles were stained with the primary antibody
against FABP for adipocytes, osteocalcin for osteoblasts, neuronal
nuclei (NeuN) for neurons and glial fibrillary acidic protein for
Schwann cells. (PPTX 409 kb)
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